TCF4 knockdown can promote ferroptosis and increase the cisplatin sensitivity of gastric cancer cells,197 suggesting that abnormal activation of Wnt/β-catenin pathway increases ferroptosis resistance in gastric cancer cells, offering a possible therapeutic strategy for enhancing chemotherapy sensitivity in patients with advanced gastric cancer. The gene discussed is TCF4; the disease is gastric cancer.